CTOs on the Move

Preferred Homecare

www.preferredhomecare.com

 
We are the Southwest`s leading provider of comprehensive home healthcare products and services. We are committed to full-service homecare solutions that give our patients mobility and independence. Preferred Homecare/Lifecare Solutions has nearly 2,000 employees in over 60 locations, 7 Pharmacies, and 5 Ambulatory Infusion Suites, across the Western United States, all committed to offer the best care possible. We offer a full range of respiratory, home infusion and home medical equipment therapies and services. We are accredited by the Accreditation Commission for Health Care (ACHC). Meeting or exceeding each and every one of ACHC`s standards demonstrates our commitment to delivering ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Kevin Sauer
 Chief Information Officer Profile

Similar Companies

EnClear Therapies

At Enclear Therapies, our mission is to halt the progression of disease and extend the lives of patients with Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP) by removing toxic proteins that build up in the brain, significantly impacting neurodegeneration.

American Dental Partners, Inc.

American Dental Partners, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

r4 Vascular

r4 Vascular, Inc. is a Maple Grove, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Electromedical Products International Inc

Electromedical Products International Inc is a Mineral Wells, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dthera

Dthera™ Sciences (OTCQB:DTHR) is the leading digital therapeutic company focusing on the elderly. The San Diego-based, publicly traded company is working to improve the lives of seniors and individuals suffering from neurodegenerative diseases, as well as those who care for them. It has two core products: ReminX™, a commercially available consumer health product for individuals suffering from social isolation and dementia; and DTHR-ALZ, and a development-stage product that has been granted Breakthrough Device designation by the FDA for the mitigation of the symptoms of agitation and depression associated with Alzheimer`s disease.